As Adaptimmune Therapeutics pulls off a $191.3m IPO, how strong is investor exuberance for immuno-oncology in the UK?
Extremely strong
Strong
Moderate
Low
Vote
View Results
See this poll on:
https://poll.fm/8853154/embed
